Clinical significance of expression of human cytomegalovirus pp67 late transcript in heart, lung, and bone marrow transplant recipients as determined by nucleic acid sequence-based amplification

Journal of Clinical Microbiology

Volumn 37, Issue 4, 1999, Pages 902-911

  Gerna, Giuseppe ^a,c   Baldanti, Fausto ^a   Middeldorp, Jaap M ^b   Furione, Milena ^a   Zavattoni, Maurizio ^a   Lilleri, Daniele ^a   Revello, Maria Grazia ^a  

^a Servizio di Virologia   (Italy)

^b Organon Teknika   (Netherlands)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; GENE AMPLIFICATION; HUMAN; HUMAN CYTOMEGALOVIRUS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIREMIA; VIRUS DETECTION;

CYTOMEGALOVIRUS; DNA VIRUSES; HUMAN HERPESVIRUS 5;

EID: 0033054671     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.4.902-911.1999     Document Type: Article

References (42)

1. Bitsch, A., H. Kirchner, R. Dupke, and G. Bein. 1993. Cytomegalovirus transcripts in peripheral blood leukocytes of actively infected transplant patients detected by reverse-transcription-polymerase chain reaction. J. Infect. Dis. 167:740-743.
2. Blok, M. J., V. J. Goossens, S. J. V. Vanherle, B. Top, N. Tacken, J. M. Middeldorp, M. H. L. Christiaans, J. P. van Hooff, and C. A. Bruggeman. 1998. Diagnostic value of monitoring human cytomegalovirus late pp67 mRNA expression in renal-allograft recipients by nucleic acid sequence-based amplification. J. Clin. Microbiol. 36:1341-1346.
3. Boivin, G., C. A. Olson, M. R. Quirk, S. M. St.-Cyr, and M. C. Jordan. 1995. Quantitation of cytomegalovirus glycoprotein H gene in cells using competitive PCR and a rapid fluorescent-based detection system. J. Virol. Methods 51:329-342.
4. Boom, R., C. J. A. Sol, M. M. M. Salimans, C. L. Jansen, P. M. E. Wertheimvan Dillen, and J. van der Nordaa. 1990 Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 28:495-503.
5. Compton, J. 1991. Nucleic acid sequence-based amplification. Nature 350: 91-92.
6. Einsele, H., G. Ehninger, H. Hebart, K. M. Wittkowski, U. Schule, G. Jahn, P. Mackes, M. Herter, T. Klingebiel, J. Loeffler, S. Wagner, and C. Muller. 1995. Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation. Blood 86:2815-2820.
7. Einsele, H., G. Ehninger, M. Steidle, A. Vallbracht, M. Muller, H. Schmidt, J. G. Saal, H. D. Waller, and C. Muller. 1991. Polymerase chain reaction to evaluate antiviral therapy for cytomegalovirus disease. Lancet 338:1170-1172.
8. Fox, J. C., P. D. Griffiths, and V. C. Emery. 1992. Quantitalion of human cytomegalovirus DNA using the polymerase chain reaction. J. Gen. Virol. 73: 2405-2408.
9. Gerna, G., F. Baldanti, A. Sarasini, M. Furione, E. Percivalle, M. G. Revello, D. Zipeto, D. Zella, and The Italian Foscarnet Study Group. 1994. Effect of foscarnet induction treatment on quantitation of human cytomegalovirus (HCMV) DNA in peripheral blood polymorphonuclear leukocytes and aqueous humor of AIDS patients with HCMV retinitis. Antimicrob. Agents Chemother. 38:38-44.
10. Gerna, G., M. Furione, F. Baldanti, E. Percivalle, P. Comoli, and F. Locatelli. 1995. Quantitation of human cytomegalovirus DNA in bone marrow transplant recipients. Br. J. Hematol. 91:674-683.
11. Gerna, G., M. Furione, F. Baldanti, and A. Sarasini. 1994. Comparative quantitation of human cytomegalovirus DNA in blood leukocytes and plasma of transplant and AIDS patients. J. Clin. Microbiol. 32:2709-2717.
12. Gerna, G., M. G. Revello, E. Percivalle, and F. Morini. 1992. Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia. J. Clin. Microbiol. 30:1232-1237.
13. Gerna, G., M. G. Revello, E. Percivalle, and M. Torsellini. 1990. A 6-hour microneutralization assay for human cytomegalovirus antibody by using monoclonal antibodies. Serodiagn. Immunother. Infect. Dis. 4:243-247.
14. Gerna, G., M. G. Revello, E. Percivalle, M. Zavattoni, M. Parea, and M. Battaglia. 1990. Quantification of human cytomegalovirus viremia by using monoclonal antibodies to different viral proteins. J. Clin. Microbiol. 28:2681-2688.
15. Gerna, G., M. Zavattoni, F. Baldanti, M. Furione, L. Chezzi, M. G. Revello, and E. Percivalle. 1998. Circulating cytomegalic endothelial cells are associated with high human cytomegalovirus (HCMV) load in AIDS patients with late-stage disseminated HCMV disease. J. Med. Virol. 55:64-74.
16. Gerna, G., M. Zavattoni, F. Baldanti, A, Sarasini, L. Chezzi, P. Grossi, and M. G. Revello. 1998. Human cytomegalovirus (HCMV) leukoDNAemia correlates more closely with clinical symptoms than antigenemia and viremia in heart and heart-lung transplant recipients with primary HCMV infection. Transplantation 65:1378-1385.
17. Gerna, G., M. Zavattoni, E. Percivalle, P. Grossi, M. Torsellini, and M. G. Revello. 1998. Rising levels of human cytomegalovirus (HCMV) antigenemia during initial antiviral treatment of solid-organ transplant recipients with primary HCMV infection. J. Clin. Microbiol. 36:1113-1116.
18. Gerna, G., D. Zipeto, M. Parea, M. G. Revello, E. Silini, E. Percivalle, M. Zavattoni, P. Grossi, and G. Milanesi. 1991 Monitoring of human cytomegalovirus infections and ganciclovir treatment in heart transplant recipients by determination of viremia, antigenemia and DNAemia. J. Infect. Dis. 164: 488-498.
19. Gleaves, C. A., T. F. Smith, E. A. Shuster, and G. R. Pearson. 1984. Rapid detection of cytomegalovirus in MRC-5 cells inoculated with urine specimens by using low-speed centrifugation and monoclonal antibody to an early antigen. J. Clin. Microbiol. 19:917-919.
20. Gozlan, J., J. M. Salord, C. Chouaïd, C. Duvivier, O. Picard, M. C. Mejohas, and J. C. Petit. 1993. Human cytomegalovirus (HCMV) late mRNA detection in peripheral blood of AIDS patients: diagnostic value for HCMV disease compared with those of viral culture and HCMV DNA detection. J. Clin. Microbiol. 31:1943-1945.
21. Gozlan, J., J. P. Laporte, S. Lesage, M. Labopin, A. Najman, N. C. Gorin, and J. C. Petit. 1996. Monitoring of cytomegalovirus infection and disease in bone marrow recipients by reverse transcription-PCR and blood and urine culture. J. Clin. Microbiol. 34:2085-2088.
22. Grefte, A., M. C. Harmsen, M. van der Giessen, S. Knollema, W. J. van Son, and T. H. The. 1994. Presence of human cytomegalovirus (HCMV) immediate early mRNA but not ppUL 83 (lower matrix protein pp65) mRNA in polymorphonuclear and mononuclear leukocytes during active HCMV infection. J. Gen. Virol. 75:1989-1998.
23. Grossi, P., S. Kusne, C. Rinaldo, K. St. George, M. Magnane, J. Rakela, J. Fung, and T. E. Starzl. 1996. Guidance of ganciclovir therapy with pp65 antigenemia in cytomegalovirus-free recipients of livers from seropositive donors. Transplantation 61:1659-1660.
24. Grossi, P., L. Minoli, E. Percivalle, W. Irish, M. Viganò, and G. Gerna. 1995. Clinical and virological monitoring of human cytomegalovirus infection in 294 heart transplant recipients. Transplantation 59:847-851.
25. Hsia, K., D. K. Spector, J. Lawrie, and S. A. Spector. 1989. Enzymatic amplification of human cytomegalovirus sequences by polymerase chain reaction. J. Clin. Microbiol. 27:1802-1809.
26. Kievits, T., B. van Gemen, D. van Strijp, R. Schukkink, M. Direks, H. Adriaanse, L. Malek, R. Sooknanan, and P. Lens. 1991. NASBA isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection. J. Virol. Methods 35:273-286.
27. Lam, K. M. C., N. Oldenburg, M. A. Khan, V. Gaylore, G. W. Mikhail, P. D. Strouhal, J. M. Middeldorp, N. Banner, and M. Yacoub. 1998. Significance of reverse transcription polymerase chain reaction in the detection of human cytomegalovirus gene transcripts in thoracic organ transplant recipients. J. Heart Lung Transplant. 17:555-565.
28. Locatelli, F., E. Percivalle, P. Comoli, R. Maccario, M. Zecca, G. Giorgiani, P. Di Stefano, and G. Gerna. 1994. Human cytomegalovirus (HCMV) infection in pediatric patients given allogeneic bone marrow transplantation: role of early antiviral treatment for HCMV antigenemia on patients' outcome. Br. J. Hematol. 88:64-71.
29. Meyer, T., U. Reischl, H. Wolf, C. Schuller, and R. Arndt. 1994. Identification of active cytomegalovirus infection by analysis of immediate early, early and late transcripts in peripheral blood cells of immunodeficient patients. Mol. Cell. Probes 8:261-271.
30. Nelson, P. N., B. K. Kawal, Y. S. Boriskin, K. E. Mathers, R. L. Powles, H. M. Steel, Y. S. Tryhorn, P. D. Butcher, and J. C. Booth. 1996. A polymerase chain reaction to detect a spliced late transcript of human cytomegalovirus in the blood of bone marrow transplant recipients. J. Virol. Methods 56:139-148.
31. Randhawa, P. S., R. Manez, B. Frye, and G. D. Ehrlich. 1994. Circulating immediate-early mRNA in patients with cytomegalovirus infections after solid organ transplantation. J. Infect. Dis. 170:1264-1267.
32. Revello, M. G., E. Percivalle, M. Zavattoni, M. Parea, P. Grossi, and G. Gerna. 1989. Detection of human cytomegalovirus immediate-early antigen in leukocytes as a marker of viremia in immunocompromised patients. J. Med. Virol. 29:88-93.
33. Revello, M. G., E. Percivalle, E. Arbustini, R. Pardi, S. Sozzani, and G. Gerna. 1998. In vitro generation of human cytomegalovirus pp65 antigenemia, viremia, and leukoDNAemia. J. Clin. Invest. 101:2686-2692.
34. Shibata, D., W. J. Martin, M. D. Appleman, D. M. Causey, J. M. Leedom, and N. A. Arnheim. 1988. Detection of cytomegalovirus DNA in peripheral blood of patients infected with human immunodeficiency virus. J. Infect. Dis. 158:1185-1192.
35. Shinkai, M., and S. A. Spector. 1995. Quantitation of human cytomegalovirus (HCMV) in cerebrospinal fluid by competitive PCR in AIDS patients with different HCMV central nervous system diseases. Scand. J. Infect. Dis. 27:559-561.
36. Shinkai, M., S. A. Bozzette, W. Powderly, P. Frame, and S. A. Spector. 1997. Utility of urine and leukocyte cultures and plasma DNA PCR for identification of AIDS patients at risk for developing human cytomegalovirus disease. J. Infect. Dis. 175:302-308.
37. Spector, S. A., R. Wong, K. Hsia, M. Pilcher, and M. J. Stempien. 1998. Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients. J. Clin. Invest. 101:497-502.
38. Van den Berg, A. P., W. van der Bij, W. J. van Son, J. Anema, M. van der Giessen, J. Schirm, A. M. Tegzess, and T. H. The. 1989. Cytomegalovirus antigenemia as a useful marker of symptomatic cytomegalovirus infection after renal transplantation - a report of 130 consecutive patients. Transplantation 48:991-995.
39. van der Bij, W., J. Schirm, R. Torensma, W. J. van Son, A. M. Tegzess, and T. H. The. 1988. Comparison between viremia and antigenemia for detection of cytomegalovirus in blood. J. Clin. Microbiol. 26:2531-2535.
40. Velzing, J., P. H. Rothbarth, A. C. M. Kroes, and W. G. V. Quint. 1994. Detection of cytomegalovirus mRNA and DNA encoding the immediate-early gene in peripheral blood leukocytes from immunocompromised patients. J. Med. Virol. 42:164-169.
41. Zipeto, D., F. Baldanti, D. Zella, M. Furione, A. Cavicchini, G. Milanesi, and G. Gerna. 1993. Quantification of human cytomegalovirus DNA in peripheral blood leukocytes of immunocompromised patients by the polymerase chain reaction. J. Virol. Methods 44:45-56.
42. Zipeto, D., M. G. Revello, E. Silini, M. Parea, E. Percivalle, M. Zavattoni, G. Milanesi, and G. Gerna. 1992. Development and clinical significance of a diagnostic assay based on the polymerase chain reaction for detection of human cytomegalovirus DNA in blood samples from immunocompromised patients. J. Clin. Microbiol. 30:527-530.